RYLIE JOHNSON: Open Payments
NPI 1952080103 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 18 payments from 12 companies in 2025. Trend: 2023 $14 · 2024 $580 · 2025 $406
Food & beverage: $336Education: $70
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| GENZYME CORPORATION | 2 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Ionis Pharmaceuticals, Inc. | 1 | $32 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $29 |
| Cycle Pharmaceuticals Inc | 1 | $22 |
| Amgen Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: DUPIXENT, AIRSUPRA, HYQVIA, NEFFY, Sajazir, NUCALA, TEZSPIRE, TRELEGY ELLIPTA.
Industry payments across NV — which companies pay providers there.
